{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:32:34Z","timestamp":1792150354693,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To assess significant radiological and clinicopathological risk factors for post-surgery recurrence in patients with intraductal papillary mucinous neoplasm (IPMN).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Patients with IPMNs who underwent surgery from 2011 to 2021 at a single center were retrospectively included. Two reviewers evaluated CT findings according to international guidelines. Clinicopathological data were collected from medical records and surgical pathology reports. Patients were monitored for recurrence with contrast-enhanced CT or MRI up to 2023. Univariable Cox regression analysis included potential risk factors: all high-risk stigmata and worrisome features in the international guidelines, age, sex, tumor location, type, carcinoembryonic antigen, surgery type, postsurgical residual cyst, adjuvant treatment, pathologic grade, type, size, margin status, lymph node metastasis, gland type, and pancreatic intraepithelial neoplasia. Variables with <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.2 were included in multivariate analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 332 patients (mean age, 66.3\u2009\u00b1\u20099.0 years; 212 men), recurrence occurred in 39 (11.7%) over a median follow-up of 3.2 years (range: 0.1\u201312.3 years). Two- and five-year recurrence-free survival rates were 91.2% and 86.4%, respectively. Significant radiological risk factors included enhancing mural nodule (EMN) presence (hazard ratio [HR] 5.088, <jats:italic>p<\/jats:italic>\u2009=\u20090.007) and lymphadenopathy (HR 2.837, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). Associated invasive carcinoma (HR 25.030), lymph node metastasis (HR 27.562), adjuvant treatment (HR 0.203), and history of pancreatitis (HR 2.608) were also significant. Most imaging features showed moderate to excellent interobserver agreement, except for thickened\/enhancing cyst walls (\u03ba, 0.25).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The presence of EMNs and lymphadenopathy, along with several clinicopathologic factors, were significantly associated with IPMN recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Question<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>Understanding postoperative recurrence risk in IPMN patients is crucial for determining surveillance strategies; however, research on radiologic risk factors remains limited<\/jats:italic>.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Findings<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>The presence of EMNs and lymphadenopathy were identified as significant radiologic risk factors for the postoperative recurrence of IPMN, along with clinicopathologic factors<\/jats:italic>.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                <jats:italic>Clinical relevance<\/jats:italic>\n              <\/jats:bold>\n              <jats:italic>IPMN recurrence is significantly associated with imaging findings like EMNs and lymphadenopathy, as well as clinical and pathologic factors. It can guide the development of tailored postoperative surveillance strategies for IPMN patients in further studies<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00330-025-11431-5","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:50:25Z","timestamp":1739991025000},"page":"5004-5016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Important radiological and clinicopathological risk factors for the recurrence of intraductal papillary mucinous neoplasms after surgical resection"],"prefix":"10.1007","volume":"35","author":[{"given":"Junghoan","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-7758","authenticated-orcid":false,"given":"Jung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Rim","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"11431_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","volume":"17","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Fern\u00e1ndez-del Castillo C, Kamisawa T et al (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17:738\u2013753. https:\/\/doi.org\/10.1016\/j.pan.2017.07.007","journal-title":"Pancreatology"},{"key":"11431_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-del Castillo C, Furukawa T et al (2024) International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 24:255\u2013270. https:\/\/doi.org\/10.1016\/j.pan.2023.12.009","journal-title":"Pancreatology"},{"key":"11431_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/SLA.0000000000004427","volume":"275","author":"MJ Pfl\u00fcger","year":"2022","unstructured":"Pfl\u00fcger MJ, Griffin JF, Hackeng WM et al (2022) The impact of clinical and pathological features on intraductal papillary mucinous neoplasm recurrence after surgical resection: long-term follow-up analysis. Ann Surg 275:1165\u20131174. https:\/\/doi.org\/10.1097\/SLA.0000000000004427","journal-title":"Ann Surg"},{"key":"11431_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/SLA.0000000000004488","volume":"276","author":"N Amini","year":"2022","unstructured":"Amini N, Habib JR, Blair A et al (2022) Invasive and noninvasive progression after resection of noninvasive intraductal papillary mucinous neoplasms. Ann Surg 276:370\u2013377. https:\/\/doi.org\/10.1097\/SLA.0000000000004488","journal-title":"Ann Surg"},{"key":"11431_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/SLA.0000000000002923","volume":"268","author":"VK Dhar","year":"2018","unstructured":"Dhar VK, Merchant NB, Patel SH et al (2018) Does surgical margin impact recurrence in noninvasive intraductal papillary mucinous neoplasms?: a multi-institutional study. Ann Surg 268:469\u2013478. https:\/\/doi.org\/10.1097\/SLA.0000000000002923","journal-title":"Ann Surg"},{"key":"11431_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3348\/kjr.2018.0640","volume":"20","author":"ES Lee","year":"2019","unstructured":"Lee ES, Kim JH, Yu MH et al (2019) Diagnosis and surveillance of incidental pancreatic cystic lesions: 2017 consensus recommendations of the Korean Society of Abdominal Radiology. Korean J Radiol 20:542\u2013557. https:\/\/doi.org\/10.3348\/kjr.2018.0640","journal-title":"Korean J Radiol"},{"key":"11431_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/SLA.0000000000001008","volume":"262","author":"G Marchegiani","year":"2015","unstructured":"Marchegiani G, Mino-Kenudson M, Ferrone CR et al (2015) Patterns of recurrence after resection of IPMN: Who, when, and how? Ann Surg 262:1108\u20131114. https:\/\/doi.org\/10.1097\/SLA.0000000000001008","journal-title":"Ann Surg"},{"key":"11431_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SLA.0000000000001817","volume":"266","author":"A Pea","year":"2017","unstructured":"Pea A, Yu J, Rezaee N et al (2017) Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg 266:133\u2013141. https:\/\/doi.org\/10.1097\/SLA.0000000000001817","journal-title":"Ann Surg"},{"key":"11431_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.surg.2014.09.028","volume":"157","author":"D Xourafas","year":"2015","unstructured":"Xourafas D, Tavakkoli A, Clancy TE, Ashley SW (2015) Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up. Surgery 157:473\u2013483. https:\/\/doi.org\/10.1016\/j.surg.2014.09.028","journal-title":"Surgery"},{"key":"11431_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jhbp.280","volume":"22","author":"T Yogi","year":"2015","unstructured":"Yogi T, Hijioka S, Imaoka H et al (2015) Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci 22:757\u2013765. https:\/\/doi.org\/10.1002\/jhbp.280","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"11431_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00535-019-01617-2","volume":"55","author":"S Hirono","year":"2020","unstructured":"Hirono S, Shimizu Y, Ohtsuka T et al (2020) Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol 55:86\u201399. https:\/\/doi.org\/10.1007\/s00535-019-01617-2","journal-title":"J Gastroenterol"},{"key":"11431_CR12","doi-asserted-by":"publisher","unstructured":"Park J, Kim JH, Bae JS, Kang H-J, Choi S-Y (2025) An imaging-based model to predict the malignant potential of intraductal papillary mucinous neoplasm of the pancreas. Eur Radiol 35:700\u2013711. https:\/\/doi.org\/10.1007\/s00330-024-11003-z","DOI":"10.1007\/s00330-024-11003-z"},{"key":"11431_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/atm.2018.02.12","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CG (2018) Time-varying covariates and coefficients in Cox regression models. Ann Transl Med 6:121. https:\/\/doi.org\/10.21037\/atm.2018.02.12","journal-title":"Ann Transl Med"},{"key":"11431_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22:276\u2013282. https:\/\/doi.org\/10.11613\/BM.2012.031","journal-title":"Biochem Med"},{"key":"11431_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"11431_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/SLA.0000000000000470","volume":"260","author":"MJ Kang","year":"2014","unstructured":"Kang MJ, Jang J-Y, Lee KB, Chang YR, Kwon W, Kim S-W (2014) Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg 260:356\u2013363. https:\/\/doi.org\/10.1097\/SLA.0000000000000470","journal-title":"Ann Surg"},{"key":"11431_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.pan.2022.07.004","volume":"22","author":"D Hashimoto","year":"2022","unstructured":"Hashimoto D, Satoi S, Yamamoto T et al (2022) Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy. Pancreatology 22:1046\u20131053. https:\/\/doi.org\/10.1016\/j.pan.2022.07.004","journal-title":"Pancreatology"},{"key":"11431_CR18","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1007\/s00261-020-02627-y","volume":"45","author":"JH Min","year":"2020","unstructured":"Min JH, Kim YK, Kim H, Cha DI, Ahn S (2020) Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines. Abdom Radiol (NY) 45:4290\u20134301. https:\/\/doi.org\/10.1007\/s00261-020-02627-y","journal-title":"Abdom Radiol (NY)"},{"key":"11431_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MPA.0b013e31820d1a03","volume":"40","author":"H Karasaki","year":"2011","unstructured":"Karasaki H, Mizukami Y, Tokusashi Y et al (2011) Localization of the most severely dysplastic\/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas. Pancreas 40:588\u2013594. https:\/\/doi.org\/10.1097\/MPA.0b013e31820d1a03","journal-title":"Pancreas"},{"key":"11431_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pan.2015.12.008","volume":"16","author":"N Kawada","year":"2016","unstructured":"Kawada N, Uehara H, Nagata S, Tsuchishima M, Tsutsumi M, Tomita Y (2016) Mural nodule of 10 mm or larger as predictor of malignancy for intraductal papillary mucinous neoplasm of the pancreas: pathological and radiological evaluations. Pancreatology 16:441\u2013448. https:\/\/doi.org\/10.1016\/j.pan.2015.12.008","journal-title":"Pancreatology"},{"key":"11431_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/MPA.0000000000000874","volume":"46","author":"S Yu","year":"2017","unstructured":"Yu S, Takasu N, Watanabe T et al (2017) Validation of the 2012 Fukuoka consensus guideline for intraductal papillary mucinous neoplasm of the pancreas from a single institution experience. Pancreas 46:936\u2013942. https:\/\/doi.org\/10.1097\/MPA.0000000000000874","journal-title":"Pancreas"},{"key":"11431_CR22","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s11605-013-2242-1","volume":"17","author":"M Winner","year":"2013","unstructured":"Winner M, Epelboym I, Remotti H et al (2013) Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections. J Gastrointest Surg 17:1618\u20131626. https:\/\/doi.org\/10.1007\/s11605-013-2242-1","journal-title":"J Gastrointest Surg"},{"key":"11431_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cncr.29803","volume":"122","author":"MT McMillan","year":"2016","unstructured":"McMillan MT, Lewis RS, Drebin JA et al (2016) The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN). Cancer 122:521\u2013533. https:\/\/doi.org\/10.1002\/cncr.29803","journal-title":"Cancer"},{"key":"11431_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.21037\/atm.2019.10.37","volume":"7","author":"L Aronsson","year":"2019","unstructured":"Aronsson L, Marinko S, Ansari D, Andersson R (2019) Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review. Ann Transl Med 7:689. https:\/\/doi.org\/10.21037\/atm.2019.10.37","journal-title":"Ann Transl Med"},{"key":"11431_CR25","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1245\/s10434-020-08916-6","volume":"28","author":"B Mungo","year":"2021","unstructured":"Mungo B, Croce C, Oba A et al (2021) Controversial role of adjuvant therapy in node-negative invasive intraductal papillary mucinous neoplasm. Ann Surg Oncol 28:1533\u20131542. https:\/\/doi.org\/10.1245\/s10434-020-08916-6","journal-title":"Ann Surg Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11431-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:16:37Z","timestamp":1751559397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11431-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["11431"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11431-5","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Jung Hoon Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board. This retrospective study was approved by our institutional review board, and patient informed consent was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This retrospective study was approved by the Institutional Review Board of our institutes (IRB no. 2311-124-1485).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects (234\/332 subjects) have been previously reported in Park et al [].","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}